India-based Aurobindo Pharma has completed the acquisition of US-based nutritional supplement maker Natrol for $132.5m.

Carried out through its wholly-owned subsidiary Aurobindo Pharma USA (APUSA), the acquisition involves purchase of assets of Natrol and other affiliate entities, under the auction process by US Bankruptcy Court for the District of Delaware, announced on 12 November.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

APUSA acquired manufacturing assets, personnel and commercial infrastructure, as well as Natrol nutraceuticals brands in US.

Natrol CEO Mesrop Khoudagoulian said: "I am pleased that Aurobindo recognises the values of Natrol’s uncompromised quality products, loyal customers, talented employees and solid relationships with our retailer partners.

"APUSA acquired manufacturing assets, personnel and commercial infrastructure, as well as Natrol nutraceuticals brands in US."

Established in 1980, Natrol produces branded products including vitamins, minerals, and supplements, diet and weight management products, sports nutrition products and formulas for hair, skin, and nails.

See Also:

The company’s brands include Natrol, MRI, Prolab, Laci Le Beau, Promensil, Trinovin, Nu Hair and Shen Min.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Aurobindo Pharma managing director Narayanan Govindarajan said: "Natrol comes with certain well established brands and an extensive distribution network consisting of retail pharmacy chains and specialty health food stores, to help us tactically position ourselves in the US nutraceuticals space and offer an effective growth strategy to expand market penetration going forward."

Aurobindo markets its products in 125 countries including antibiotics, anti-retrovirals, chorionic villus sampling (CVS), central nervous system (CNS), gastroenterologicals and anti-allergics.